Novavax Submits Request to Expand Conditional Marketing Author...
- Written by LATEST ASIANET NEWS RELEASES
- Published in Asia Net
GAITHERSBURG, Md., March 31, 2022 /PRNewswire-AsiaNet/ -- - If granted, Nuvaxovid (TM) COVID-19 Vaccine (recombinant, adjuvanted) would be the first protein-based option for adolescents aged 12-17years in EuropeNovavax, Inc. (Nasdaq: NVAX), a biotechnology company dedic...
Authors: LATEST ASIANET NEWS RELEASES